Matches in SemOpenAlex for { <https://semopenalex.org/work/W2724614897> ?p ?o ?g. }
- W2724614897 endingPage "645" @default.
- W2724614897 startingPage "631" @default.
- W2724614897 abstract "Pancreatic cancer (PC) incidence rates are rapidly increasing in developed countries, with half the patients being metastatic at diagnosis. For decades, fluorouracil, then gemcitabine regimens were the preferred palliative first-line options for fit patients with metastatic PC. FOLFIRINOX (a combination of bolus and infusional fluorouracil, leucovorin, irinotecan and oxaliplatin) was introduced to clinical practice in 2010 due to the results of the phase II/III trial (PRODIGE 4/ACCORD 11) comparing FOLFIRINOX with single-agent gemcitabine as first-line treatment for patients with MPC. Median overall survival, progression-free survival, and objective response rate were superior with FOLFIRINOX over gemcitabine and there was prolonged time to definitive deterioration in quality of life. Although FOLFIRINOX was also associated with increased toxicity, mainly febrile neutropenia and diarrhea, there has been rapid uptake of this regimen. This review closely examines optimal management and prevention of toxicities, international recommendations for first-line treatment, and use of modified FOLFIRINOX protocols. In this review, we also look at the potential benefit of FOLFIRINOX in selected groups of patients: second-line therapy, adjuvant chemotherapy, induction therapy in patients with borderline resectable and locally advanced PC. Robust validation of the FOLFIRINOX regimen in these settings requires confirmation in further randomized trials." @default.
- W2724614897 created "2017-07-14" @default.
- W2724614897 creator A5015888185 @default.
- W2724614897 creator A5020997210 @default.
- W2724614897 creator A5079681769 @default.
- W2724614897 date "2017-06-27" @default.
- W2724614897 modified "2023-10-12" @default.
- W2724614897 title "Current status on the place of FOLFIRINOX in metastatic pancreatic cancer and future directions" @default.
- W2724614897 cites W1190748217 @default.
- W2724614897 cites W1615726156 @default.
- W2724614897 cites W1675493788 @default.
- W2724614897 cites W1727989948 @default.
- W2724614897 cites W1864471800 @default.
- W2724614897 cites W1864593475 @default.
- W2724614897 cites W1906085213 @default.
- W2724614897 cites W1931508686 @default.
- W2724614897 cites W1967411786 @default.
- W2724614897 cites W1968812902 @default.
- W2724614897 cites W1971806112 @default.
- W2724614897 cites W1988100595 @default.
- W2724614897 cites W2003859804 @default.
- W2724614897 cites W2012005360 @default.
- W2724614897 cites W2023335214 @default.
- W2724614897 cites W2027389238 @default.
- W2724614897 cites W2034790774 @default.
- W2724614897 cites W2038012547 @default.
- W2724614897 cites W2054625398 @default.
- W2724614897 cites W2107780185 @default.
- W2724614897 cites W2117105709 @default.
- W2724614897 cites W2121608920 @default.
- W2724614897 cites W2123925770 @default.
- W2724614897 cites W2136866696 @default.
- W2724614897 cites W2141087037 @default.
- W2724614897 cites W2151253787 @default.
- W2724614897 cites W2158134441 @default.
- W2724614897 cites W2159140139 @default.
- W2724614897 cites W2164286021 @default.
- W2724614897 cites W2165480504 @default.
- W2724614897 cites W2168645047 @default.
- W2724614897 cites W2168781879 @default.
- W2724614897 cites W2171950337 @default.
- W2724614897 cites W2180151391 @default.
- W2724614897 cites W2182612172 @default.
- W2724614897 cites W2183237771 @default.
- W2724614897 cites W2203611750 @default.
- W2724614897 cites W2317504614 @default.
- W2724614897 cites W2323248054 @default.
- W2724614897 cites W2324457843 @default.
- W2724614897 cites W2330075233 @default.
- W2724614897 cites W2331739830 @default.
- W2724614897 cites W2336712664 @default.
- W2724614897 cites W2340641404 @default.
- W2724614897 cites W2345269414 @default.
- W2724614897 cites W2345822778 @default.
- W2724614897 cites W2407413178 @default.
- W2724614897 cites W2409856225 @default.
- W2724614897 cites W2415398754 @default.
- W2724614897 cites W2416383077 @default.
- W2724614897 cites W2418647446 @default.
- W2724614897 cites W2472707660 @default.
- W2724614897 cites W2480793872 @default.
- W2724614897 cites W2486567002 @default.
- W2724614897 cites W2515594797 @default.
- W2724614897 cites W2518765238 @default.
- W2724614897 cites W2520774580 @default.
- W2724614897 cites W2535629861 @default.
- W2724614897 cites W2539230415 @default.
- W2724614897 cites W2559029437 @default.
- W2724614897 cites W2559912395 @default.
- W2724614897 cites W2565148034 @default.
- W2724614897 cites W2570618306 @default.
- W2724614897 cites W2571282247 @default.
- W2724614897 cites W4210976084 @default.
- W2724614897 cites W4229719081 @default.
- W2724614897 cites W4232531301 @default.
- W2724614897 doi "https://doi.org/10.1177/1756283x17713879" @default.
- W2724614897 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5557187" @default.
- W2724614897 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28835777" @default.
- W2724614897 hasPublicationYear "2017" @default.
- W2724614897 type Work @default.
- W2724614897 sameAs 2724614897 @default.
- W2724614897 citedByCount "35" @default.
- W2724614897 countsByYear W27246148972017 @default.
- W2724614897 countsByYear W27246148972018 @default.
- W2724614897 countsByYear W27246148972019 @default.
- W2724614897 countsByYear W27246148972020 @default.
- W2724614897 countsByYear W27246148972021 @default.
- W2724614897 countsByYear W27246148972022 @default.
- W2724614897 countsByYear W27246148972023 @default.
- W2724614897 crossrefType "journal-article" @default.
- W2724614897 hasAuthorship W2724614897A5015888185 @default.
- W2724614897 hasAuthorship W2724614897A5020997210 @default.
- W2724614897 hasAuthorship W2724614897A5079681769 @default.
- W2724614897 hasBestOaLocation W27246148971 @default.
- W2724614897 hasConcept C121608353 @default.
- W2724614897 hasConcept C126322002 @default.
- W2724614897 hasConcept C141071460 @default.
- W2724614897 hasConcept C143998085 @default.